These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 24153173

  • 1. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL, Ogden K, Robertson IK, Broadhurst S, Edis D.
    Spine (Phila Pa 1976); 2014 Jan 15; 39(2):164-71. PubMed ID: 24153173
    [Abstract] [Full Text] [Related]

  • 2. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG, Aichmair A, Sama AA, Hughes AP, Lebl DR, Cammisa FP, Girardi FP.
    Spine J; 2014 Feb 01; 14(2):217-24. PubMed ID: 24269858
    [Abstract] [Full Text] [Related]

  • 3. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW, Branch CL, Alexander JT, Burkus JK.
    Spine J; 2004 Feb 01; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [Abstract] [Full Text] [Related]

  • 4. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ, Josey R, Reynolds J.
    Spine J; 2007 Feb 01; 7(3):301-7. PubMed ID: 17482113
    [Abstract] [Full Text] [Related]

  • 5. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD, Kim JY.
    J Orthop Surg Res; 2017 Aug 25; 12(1):126. PubMed ID: 28841904
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR, Glassman SD, Burkus KJ, Carreon LY.
    Spine (Phila Pa 1976); 2006 Oct 15; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [Abstract] [Full Text] [Related]

  • 7. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD.
    Spine (Phila Pa 1976); 2009 Jun 01; 34(13):1390-4. PubMed ID: 19440166
    [Abstract] [Full Text] [Related]

  • 8. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM, Parker RM, Ellis NJ, Blecher CM, Chow FY, Claydon MH.
    J Neurosurg Spine; 2014 Dec 01; 21(6):851-60. PubMed ID: 25279655
    [Abstract] [Full Text] [Related]

  • 9. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD, Gum JL, Crawford CH, Shields CB, Carreon LY.
    Spine J; 2011 Jun 01; 11(6):522-6. PubMed ID: 20598649
    [Abstract] [Full Text] [Related]

  • 10. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
    Rahman RK, Buchowski JM, Stephens B, Dorward IG, Koester LA, Bridwell KH.
    Spine (Phila Pa 1976); 2013 Dec 15; 38(26):2264-71. PubMed ID: 24108280
    [Abstract] [Full Text] [Related]

  • 11. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV, Marquez-Lara A, Fineberg SJ, Pelton M, Singh K.
    Spine (Phila Pa 1976); 2014 Feb 01; 39(3):185-91. PubMed ID: 24253788
    [Abstract] [Full Text] [Related]

  • 12. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1128-36. PubMed ID: 23370679
    [Abstract] [Full Text] [Related]

  • 13. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K, Nandyala SV, Marquez-Lara A, Cha TD, Khan SN, Fineberg SJ, Pelton MA.
    Spine J; 2013 Sep 01; 13(9):1118-25. PubMed ID: 24029138
    [Abstract] [Full Text] [Related]

  • 14. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR, Pearce KR, McAnany SJ, Peters CM, Gupta MC, Zebala LP.
    Spine J; 2018 Mar 01; 18(3):439-446. PubMed ID: 28822825
    [Abstract] [Full Text] [Related]

  • 15. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.
    Vaidya R, Sethi A, Bartol S, Jacobson M, Coe C, Craig JG.
    J Spinal Disord Tech; 2008 Dec 01; 21(8):557-62. PubMed ID: 19057248
    [Abstract] [Full Text] [Related]

  • 16. The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis.
    Michielsen J, Sys J, Rigaux A, Bertrand C.
    J Bone Joint Surg Am; 2013 May 15; 95(10):873-80. PubMed ID: 23677353
    [Abstract] [Full Text] [Related]

  • 17. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1137-45. PubMed ID: 23354111
    [Abstract] [Full Text] [Related]

  • 18. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Pradhan BB, Bae HW, Dawson EG, Patel VV, Delamarter RB.
    Spine (Phila Pa 1976); 2006 May 01; 31(10):E277-84. PubMed ID: 16648733
    [Abstract] [Full Text] [Related]

  • 19. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
    Park DK, Kim SS, Thakur N, Boden SD.
    Spine (Phila Pa 1976); 2013 May 20; 38(12):E738-47. PubMed ID: 23474598
    [Abstract] [Full Text] [Related]

  • 20. Incidence and outcome of graft resorption in anterior lumbar interbody fusion: using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Kayanja M, Orr RD.
    Spine (Phila Pa 1976); 2014 Mar 01; 39(5):374-80. PubMed ID: 24299714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.